009420 - Hanall Biopharma Co., Ltd.

009420 Summary
Biopharma
Stock Price & Overview
₩54,700 +800 (+1.48%) Close · Sep 4, 2026 KST
KOSPI | ₩KRW | Close: ₩54,700  ≈ US$39  ·  Market cap ₩2.9tn (≈ $2.0bn)

009420 Stock Price

40K60Kprev 54Kpeak 71KOctNovDecJan ’26FebMarAprMayJunJulAugSep55K
52 Week Range
₩30,700₩70,700
Day Range
₩53,000₩55,200
Market Cap
₩2.9tn
P/E (TTM)
n/a (loss)
P/B
17.68x
P/S (TTM)
17.57x
Volume
180,083
Shares Out
52.2M
Prev. Close
₩53,900
vs 52W High
-22.6%
Multiples use the close and the financials that were public on that date (DART), the same series as the Valuation tab — they are not vendor figures.

009420 Analysis

See all »

Nothing written yet for this company.

009420 News

See all »

No news written yet.

009420 Momentum

Period009420KOSPIDifference
1 week-15.3%-1.5%-13.8%
1 month+5.2%+5.2%+0.0%
3 months-1.3%-22.6%+21.3%
6 months+11.2%+31.3%-20.1%
Year to date+25.0%+58.7%-33.7%
1 year+68.6%+108.9%-40.4%

Closed at 60% of the way from its 52-week low (₩30,700) to its 52-week high (₩70,700).

Price return on KRX closes, KOSPI on the same dates, no dividends. A period starts at the last trading day on or before the calendar date.

009420 Filings

See all »
DART

Half-Year Report

Periodic08/14/26title translated
DART

Investor Relations Event

IR07/31/26title translated
DART

Preliminary Consolidated Results (Fair Disclosure)

Earnings07/29/26title translated
DART

Material matter affecting investment judgment ×2

Filing07/22/26title translated
Korean issuers file to DART, not the SEC. Titles are translated; where kstock has read the filing the row carries the explanation.

009420 Company Profile

Hanall Biopharma Co., Ltd. makes prescription medicines in South Korea. It is listed on KOSPI, was founded in 1973, is based in Daejeon, and has revenue of hundreds of billions of won.

SectorBiopharmaEmployees
MarketKOSPIFounded1973
Korean name한올바이오파마Head officeDaejeon

Similar to 009420

SymbolLast Price
298380ABL Bio Inc.₩71,400
+5.6%
000250Samchundang Pharm₩157,000
+1.0%
087010Peptron, Inc.₩157,300
+7.3%
141080LigaChem Biosciences Inc.₩92,000
+4.2%
145020Hugel, Inc.₩244,000
+1.5%
302440SK Bioscience Co., Ltd.₩37,900
+0.4%
310210Voronoi, Inc.₩153,000
+3.9%
214370Caregen Co., Ltd.₩44,500
+1.5%
347850D & D Pharmatech, Inc.₩49,200
+1.4%
237690ST Pharm Co., Ltd.₩101,200
+2.2%
Compare all 48 in Biopharma

What a US investor should know

  • Trading hours09:00–15:30 KST — 20:00–02:30 US Eastern the night before.
  • Daily limitKorean stocks can move at most ±30% in a session before trading halts.
  • Getting exposureKRX shares are not directly tradable in most US brokerage accounts. The usual routes are Korea ETFs or an international account.
  • ReportingKorean issuers file to DART, not the SEC. Half-year and quarterly reports land about 45 days after period end.